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show TNF-a targets molecules that regulate calcium signaling. Inositol-1,4,5-trisphosphate recep-
tors (IP3Rs) are important calcium channel responsible for evoking intracellular calcium oscillation.
We found that TNF-a increased the expression of IP3R1 and promoted osteoclastogenesis in RANKL-
induced mouse BMMs. Phosphatidylcholine-speciﬁc phospholipase C (PC-PLC) speciﬁc inhibitor
D609 eliminated the upregulation of IP3R1 by TNF-a, and decreased the autoampliﬁcation of
nuclear factor of activated T-cells 1 (NFATc1), thus resulted in less osteoclasts formation. However,
D609 did not inhibit RANKL-induced osteoclastogenesis. Our data suggest TNF-a promotes
RANKL-induced osteoclastogenesis, at least partially, through PC-PLC/IP3R1/NFATc1 pathway.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Osteoclast, derived from mononuclear progenitors of pluripo-
tent hematopoietic stem cells, is multinucleated cell and unique
in its ability to resorb mineralized tissues like bone. It has been
well accepted that two factors are critically required for osteo-
clastogenesis: macrophage-colony stimulating factor (M-CSF) and
ligand of receptor activator of NF-jB (RANKL). Two receptors,
c-Fms and RANK, mediate the functions of M-CSF and RANKL,
respectively [1]. Considerable progress has been made in our
understanding of the signals downstream M-CSF and RANKL. The
major breakthroughs include the identiﬁcation of nuclear factor
of activated T-cells c1 (NFATc1), a master osteoclastogenic tran-
scription factor, and the co-stimulatory signaling essential for acti-
vation of NFATc1 through Ca2+ signaling activation [2,3].
Higher level of TNF-a have been found in many diseases, such
as rheumatoid arthritis, periodontal disease and aseptic peripros-
thetic osteolysis. These diseases are characterized by bone loss
around affected joints or teeth caused by increased osteoclasticchemical Societies. Published by E
d T-cells c1; NF-jB, nuclear
TNF-a, tumor necrosis factor-
C-PLC, phosphatidylcholine-
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yingwei@sdu.edu.cn (Y. Hu).bone resorption. The importance of TNF-a in the pathogenesis of
various forms of bone loss is supported by both experimental
and clinical evidences [4–9]. Much effort has been made in trying
to clarify its mechanisms during osteoclastic differentiation and
bone degradation [10–13]. Takayanagi et al. demonstrated that
the effect of TNF-a was RANK-independent. Signaling molecules
immediately activated by RANKL stimulation, such as NF-jB or
TNF receptor associated factor 6 (TRAF6), were not involved in
osteoclastogenesis induced by TNF-a, while prominent NFATc1
expression was evoked in the late stage of osteoclast differentia-
tion [14–16]. Ivashkiv et al. identiﬁed delayed signaling responses
induced by TNF-a in primary human macrophages and found a
sustained wave of Ca2+ oscillations started after one-two day of
TNF-stimulation. Their work further revealed that Ca2+ signaling
culminated and caused induction and activation of NFATc1. Evoked
NFATc1 mediated a gene expression program linked to cell fusion
and osteoclast differentiation [17]. It was then concluded that
TNF-a targets molecules which regulate calcium signaling.
Inositol-1,4,5-trisphosphate receptors (IP3Rs) are large tetra-
meric transmembrane proteins found primarily in the endoplasmic
reticulum (ER), where they mediate release of intracellular calcium
stores in response to extracellular signals [18]. The calcium-
releasing function of IP3R channel is regulated by its principal
ligands, such as inositol-1,4,5-trisphosphate, calcium ions and
some interaction proteins including kineases for which IP3R is a
substrate. There are three subtypes of IP3R: IP3R1, IP3R2, andlsevier B.V. All rights reserved.
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speciﬁc manner. Different subtype of IP3R mediates different Ca2+
signaling. Among the IP3Rs, IP3R2 is known to be the most sensi-
tive to IP3 and is required for long lasting Ca2+ oscillation [19],
while IP3R1 mediates less regular Ca2+ oscillation and IP3R3 gener-
ates only monophasic Ca2+ transients. The three subtypes have
been found expressing in mouse osteoclast precursor cells [20].
There are articles reported that over-expression of IP3R1 enhanced
both IP3-binding activity and sensitivity, resulting in more active
Ca2+-releasing activity which exits in disease [21]. For example,
elevated IP3R1 might be related to initiating or perpetuating dis-
eases such as atrial ﬁbrillation and asthma [22,23]; IP3R1 upregu-
lation induced by TNF-a correlated with alterations in Ca2+
homeostasis and might be associated with Parkinson’s disease
[24]. Therefore, we hypothesize that increased IP3R1, induced by
TNF-a, stimulates calcium oscillation and enhance the autoampli-
ﬁcation of NFATc1, thus further promotes the RANKL-induced
osteoclastogenesis in vitro.
2. Materials and methods
All use of experimental animals complied with the national
guidelines in China and the experimental procedures were proved
by the Shandong University Medical College, Institutional Animal
Care and Use Committee.
2.1. Materials
Recombinant mouse Tumor necrosis factor-a (rmTNF-a,
410-MT-010), Receptor Activator for Nuclear Factor-j B Ligand
(rmRANKL, 462-TEC-010) and macrophage colony-stimulating fac-
tor (rmM-CSF, 416-ML-050) were from R&D Systems (Minneapolis,
MN, USA).a-minimumessentialmedium (a-MEM, 12571), fetal bo-
vin serum (FBS, 10099) and Hanks balanced salt solution (HBSS,
14025) were purchased from Gibco (USA). 20,70-dichloroﬂuorescein
diacetate (DCFH-DA, D6883), Histopaque-1077 (Ficoll, 1077-1),
PC-PLC speciﬁc inhibitor D609 (tricyclodecan-9-yl-xanthogenate,
T8543) and tartrate-resistant acid phosphatase (TRAP) staining kit
(387A-1KT) were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). Micro BCA™ Protein Assay kit was from Pierce (23235,
USA). Rabbit polyclonal antibody against IP3R1 was from Lifespan
bioscience (LS-B2640, USA). Anti-NFATc1 antibody was from Santa
Cruz Biotechnology (sc-13033, USA) and anti-b-actin antibody
was from Abcam (ab1801, USA). RNeasy Mini Kit for total RNA iso-
lation was from QIAGEN (74106, Valencia, CA, USA). Reverse tran-
scription reagents including Oligo(dT)12–18 Primer (18418-012),
RNaseOUT™ Recombinant Ribonuclease Inhibitor (10777-019),
Deoxyribonuclease I, Ampliﬁcation Grade (18068-015), SuperScript
III Reverse Transcriptase (18080-093, 18080-044, 18080-085) were
purchased from Invitrogen (USA). Fluo-3AM calcium probe and Plu-
ronic F127 were from Biotium (50013, USA).
2.2. Cell culture and differentiation
Six to eight weeks old male mice were sacriﬁced by decapita-
tion under deep anesthesia with 10% Chloral hydrate. Bone marrow
cells were isolated from tibiae and femurs. The cells were cultured
in a-MEM containing 10% heat-inactivated FBS, 100 U/ml penicillin
G, and 100 lg/ml streptomycin at 37 C overnight under 5% CO2.
Non-adherent cells were carefully layered onto a Ficoll (Hist-
opaque-1077) density gradient solution and centrifuged at 400 g
for 30 min at room temperature. Cells lying in the upper layer were
harvested as bone marrow derived monocytes (BMMs) and washed
with PBS. The cells were seeded into 6-well plate (5  105 cells/
well) or 96-well-plate (1  104 cells/well) and exposed to themedium supplemented with 50 ng/ml M-CSF. 1 ng/ml RANKL and
3 ng/ml TNF-a were added at the start of induction. D609
(10 lM) pretreatment was performed 1 h before induction.
2.3. TRAP staining
To evaluate osteoclast differentiation cells were stained for
tartrate-resistant acid phosphatase (TRAP). Cells were ﬁxed with
4% formaldehyde for at least 15 min at room temperature and
stained for TRAP using Acid Phosphatase, leukocyte kit according
to manufacturer’s protocol. Multinucleated TRAP-positive cells
with at least 3 nuclei were scored as osteoclasts. Osteoclast cell
number was counted under a light microscope at 20 magniﬁca-
tion. The experiments, each with triplicates, were performed on
at least three different occasions.
2.4. Assay of cell viability
Cells were seeded into 96-well plates and induced to differenti-
ate. The viability of cells was determined according to the method
of MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphe-nyltetrazolium)
assay. The absorbance was measured at 490 nm with a microplate
(Bio-tek Synergy™ HT, USA).
2.5. Assay of intracellular ROS
Cells cultured in 96-well plates were washed at certain time
point with PBS and then incubated in a-MEM containing 10 lM
DCFH-DA, 37 C for 1 h under 5% CO2. At the end of the incubation,
the cells were washed in serum-free medium three times. 100 ll
a-MEM was added to each experimental well. Culture medium
without cells was used as negative control. The DCF (20,70-dichloro-
ﬂuorescein) ﬂuorescent absorbance was determined by measuring
the ﬂuorescence emission at 525 nm with a ﬂuorescence micro-
plate reader (Bio-tek Synergy™ HT, USA). The absorbance of nega-
tive control was subtracted from samples. Relative intracellular
ROS production was calculated as following formula:
Relative intracellular ROS production
¼ DCF fluorance
MTT 490 nm absorbance2.6. Cytosolic Ca2+ measurement
Cells were seeded into confocal microscopy dishes and induced
to differentiate for 48 h. They were washed three times with Hanks
balanced salt solution (HBSS) and incubated for 30 min at 37 Cwith
5 lMFluo-3AMand 0.04% Pluronic F127.Wash the cells three times
with HBSS again and intracellular Ca2+-bound Fluo-3 ﬂuorescence
was recorded at 1s intervals for 120 s by a laser-scanning confocal
microscopy.
2.7. Semiquantitative RT-PCR
Total RNA was extracted from cells cultured in 6-well plates by
using RNeasy Mini Kit according to the manufacturer’s instruc-
tions. cDNA was synthesized from 1 lg total RNA using the Super-
Script reverse transcriptase system in a total volume of 20 ll. 2 ll
of the resulting cDNA products were subjected to PCR analysis
using speciﬁc primers. Sequence and optimal annealing tempera-
ture for each primer are presented as Table 1.
PCR ampliﬁcation was run according to the reaction proﬁle:
initial setup at 95 C for 3 min,30 ampliﬁcation cycles consisting
of denaturation for 30 s at 95 C and annealing for 30 s, ﬁnal step
is extension for 1 min at 72 C. PCR products were separated by
Table 1
Primer sequences and optimal annealing temperatures.
IP3R1 Forward 50-AACTGTGGGACCTTCACCAG-30 62 C NM_010585.4
Reverse 50-AACTCTCGCCAGTTTCTGGA-30
IP3R2 Forward 50-GTTACAGGATGTCGTGGCCT-30 62 C NT_039361.6
Reverse 50-ATTCGCCGTAATGTGCTACC-30
IP3R3 Forward 50-CAATGAGCACCACGAGAAGA-30 62 C NW_001030605.1
Reverse 50-AACTTGACAGGGGTCACCAG-30
NFATc1 Forward 50-TTCCTTCAGCCAATCATCCCCCCAGTTAC-30 65 C NW_001030635.1
Reverse 50-CGATGTCTGTCTCCCCTTTCCTCAGCTC-30
GAPDH Forward 50-GTCGTGGAGTCTACTGGCGTC-30 58 C XM_003085777.1
Reverse 50-GAAGTCACAGGAGACAACCTGG-30
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gel with ethidium bromide. The images and the intensities of
bands were obtained using FluorChem (Alpha Innotech, USA).
2.8. Western blot analysis
Cells from 6-well culture plates were lysed in ice-cold RIPA lysis
buffer [50 mM Tris(pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% so-
dium deoxycholate, 0.1% SDS, 2 mM sodium pyrophosphate,
25 mM b-glycerophosphate, 1 mM EDTA, 1 mM Na3VO4, 0.5 lg/ml
leupeptin], containing 1 mM Phenylmethanesulfonyl ﬂuoride
(PMSF). Cell debris was removed by centrifugation at 10,000 rpm
for 15 min at 4 C. Protein concentration wasmeasured usingMicro
BCA™ Protein Assay kit. Protein was denatured by boiling for 3 min
before electrophoresis. 30 lg of each protein sample was subjectedFig. 1. TNF-a promotes RANKL-induced osteoclastogenesis not through ROS pathway. (
ﬁxed and stained for TRAP. (B) TRAP-positive multinucleated cells with three or more nuc
production. The values are expressed as mean ± SD (n = 4). ⁄Represents vs. undiff. Und
without RANKL and TNF-a stimulation.to 6% SDS–PAGE, and transferred to Nitroate cellulose (NC) mem-
brane. Themembranewas blockedwith 3% BSA in Tris-buffered sal-
ine containing 0.1% Tween 20 (TBS-T) for 1 h, and incubated with
anti-IP3R1 or NFATc1 antibody at room temperature for 2 h, fol-
lowed by washing with TBS-T for 5 min three times. After incuba-
tion with HRP-conjugated anti-rabbit IgG antibody at room
temperature for 1 h, and washing with TBS-T for 5 min three times,
signals were developed using Immubilon Western Chemilumines-
cent HRP substrate for 1 min. The images and the intensities of
bands were obtained using FluorChem (Alpha Innotech).
2.9. Data analysis
Data are presented as means ± standard deviations (SD) from at
least 3 different experiments. Student’s t-test was used forA) TRAP staning. BMMs stimulated by RANKL with or without TNF-a for 72 h were
lei were counted. (C) Instant intracellular ROS production. (D) Late intracellular ROS
iff is the abbreviation of undifferentiated group which represents cultured BMMs
3344 L. Xia et al. / FEBS Letters 586 (2012) 3341–3348statistical analysis. P < 0.05 (⁄) was considered statistically signiﬁ-
cant. ⁄⁄P < 0.01, ⁄⁄⁄P < 0.005.
3. Results
3.1. TNF-a promotes RANKL-induced osteoclastogenesis not through
ROS pathway
It has been reported that long term ROS production induced by
RANKL mediates the Ca2+ oscillations and regulates osteoclast dif-
ferentiation [25]. TNF-a targets molecules which regulate calcium
signaling. Thus we speculate that intracellular ROS level is involved
in osteoclastogenesis induced by TNF-a.
BMMs were treated by RANKL and M-CSF. TNF-a was added to
the cultures at the start of stimulation. After 72 h cells were
stained for tartrate-resistant acid phosphatase (TRAP). TRAP-posi-
tive multinucleated cells (MNCs) with more than three nuclei were
scored as osteoclasts and the number of osteoclasts was counted
(Fig. 1A). Compared to RANKL- stimulation, adding TNF-a to
RANKL treatment dramatically increased the number of TRAP-posi-
tive MNCs (P < 0.005, Fig. 1B). Relative intracellular ROS level was
measured with a ﬂuoresce probe DCFH-DA at different time point.
There was no obvious change of ROS level detected until 24 h of
RANKL stimulation. Addition of TNF-a did not alter intracellular
ROS level after 24 h stimulation (Fig. 1 C and D).
3.2. PC-PLC inhibitor D609 doesn’t inhibit osteoclastogenesis induced
by RANKL but removes the promotional effect of TNF-a
Since there was no further promotion of intracellular ROS
production by TNF-a, we checked other signaling moleculesFig. 2. PC-PLC speciﬁc inhibitor D609 reduces the promotional effect of TNF-a on RANKL-
of MTT. (B) BMMs stimulated by RANKL with or without TNF-a and D609 for 72 h were
three or more nuclei were counted. The values are expressed as mean ± SD, n = 4. ⁄repreinvolved in TNF-a effect on osteoclastogenesis. PC-PLC, a molecule
that produces DAG and phosphorylcholine from phosphatidylcho-
line (PC) hydrolysis, is reported to mediate TNF-a signaling in
various cells [26–28]. Then we wondered whether the enzyme
participates in stimulatory effect of TNF-a during osteoclast
differentiation. To test this, PC-PLC speciﬁc inhibitor D609 was
incubated with BMMs for 1 h before the cells were exposed to
RANKL or RANKL plus TNF-a. The toxicity of D609 was excluded
by measuring cellular viability with the method of MTT (Fig. 2A).
Cells were stained for TRAP after 72 h of stimulation (Fig. 2B).
D609 moderately increased the number of TRAP-positive MNCs
induced by RANKL (P < 0.05, Fig. 2C), but remarkably decreased
the number in the group of RANKL combining TNF-a (P < 0.01,
Fig. 2C).
3.3. PC-PLC is involved in the regulation of intracellular Ca2+ signaling
and NFATc1 autoampliﬁcation by TNF-a
NFATc1 is an important transcription factor during osteoclasto-
genesis both in vitro and in vivo. Previous reports showed that
TNF-a promoted autoampliﬁcation of NFATc1 as a result of
enhanced Ca2+ oscillations in primary human macrophages [17].
As the results showed above that PC-PLC was involved in the the
promotion of TNF-a on osteoclast formation, we examined if PC-
PLC participated in the upregulation of Ca2+ oscillations and
NFATc1 by TNF-a. For NFATc1 examination, primary mouse BMMs
were seeded into 6-well plates and total RNAs were extracted after
48-h stimulation by RANKL with or without TNF-a. PCR results
were shown in Fig. 3A and B. The presence of TNF-a in RANKL-cul-
ture upregulated mRNA expression of NFATc1, the increasing effect
was eliminated when the cells were pre-treated by D609. Theinduced osteoclast formation (A) The toxicity of D609 was measured by the method
ﬁxed and stained by TRAP staining kit. (C) TRAP-positive multinucleated cells with
sents vs. RANKL, # vs. RANKL plus TNF-a.
Fig. 3. PC-PLC is involved in the regulation of intracellular Ca2+ signaling and NFATc1 autoampliﬁcation by TNF-a. BMMs were stimulated for 48 h by RANKL with or without
TNF-a, RT-PCR and Western blot were performed to determine mRNA (A and B) and protein (C and D) expression of NFATc1. Data was pooled from at least three different
experiments. ⁄represents vs. RANKL, # vs. RANKL plus TNF-a. (E) Intracellular Ca2+ oscillations were measured with confocal microscope at 1s intervals for 120 s. Each color
indicates a different cell in the same ﬁeld.
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gated at protein level after 48 h stimulation. Western blot results
were consistent with the mRNA changes (Fig. 3C and D). For mea-
surement of Ca2+ oscillations, we examined the cells loaded by cal-
cium probe with a confocal microscope. As shown in Fig. 3E, TNF-a
promoted intracellular Ca2+ oscillations, and D609 inhibited the
promotion effect induced by TNF-a.3.4. TNF-aenhances Ca2+-NFATc1 axis by upregulating the expression
of IP3R1, but not IP3R2 or IP3R3
It is mentioned by other group that TNF-a increases the expres-
sion of IP3R1 at both mRNA and protein levels in human neural
cells and mesangial cells [24,29], we investigated whether the
factor shows the similar effect in mouse BMMs under induction
Fig. 4. TNF-a enhances Ca2+-NFATc1 axis by increasing the expression of IP3R1, but not IP3R2 or IP3R3. BMMs were stimulated for 48 h by RANKL with or without TNF-a, (A)
PT-PCR were performed to determine mRNA expression of IP3R1 (B), IP3R2 (C), and IP3R3 (D). Expression of IP3R1 protein level (E and F) was determined by western blot.
Data are representative of 3 independent experiments. ⁄represents vs. RANKL, # vs. RANKL plus TNF-a.
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mRNA expressions of all three types of IP3Rs. Expression of all
the three receptors was detectable in RANKL-induced BMM, while
addition of TNF-a caused different changes of the expression of the
three subtypes. IP3R1 mRNA was raised by the addition of TNF-a
consistent with its upregulation in autoampliﬁcation of NFATc1
(Fig. 4A and B). No obvious alterations of IP3R2 and IP3R3 mRNA
expression were detected (Fig. 4A, C and D). We further investi-
gated the role of PC-PLC in IP3R1 mRNA expression by using its
speciﬁc inhibitor D609. D609 inhibited the promotional effect of
TNF-a in RANKL-induced osteoclast differentiation without chang-
ing basal level of IP3R1 expression. As proved by Western blot en-
hanced IP3R1 at transcription level resulted in higher steady-state
level of protein (Fig. 4E and F).4. Discussion
Higher level of TNF-a have been detected in many diseases
which are characterized by increased osteoclastic bone resorption,
such as periodontitis and osteoporosis. It is universally accepted
that TNF-a promotes RANKL-induced osteoclast formation both
in vitro and in vivo. However, the molecular mechanism of the
promotion has not been elucidated yet. Accumulating evidences
indicate that TNF-a leashes this effect by direct acting on osteo-
clast precursor cells but not through supporting mesenchymal cells
[5,30], and the direct effect plays a critical role under certain
conditions in vivo [30]. TNF-a is found to affect osteoclast differen-
tiation at late stage when sustained calcium oscillation and NFATc1
autoampliﬁcation are active [14–16].
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in RANKL-induced osteoclastogenesis is not well studied. It has
been recently found that TNF-a induces calcium oscillation after
several days of culture [17]. Yip et al. have reported that Ca2+
–ATPase inhibitor Thapsigargin(TG) promoted RANKL-induced
osteoclastogenesis and elevated intracellular ROS production[31].
They found that low concentration(10 nM) of TG which was not
sufﬁcient to raise basal level of intracellular calcium promote
osteoclast formation and ROS production. However, the oscilla-
tions of calcium was not determined by their study. Long time last-
ing ROS production induced by RANKL is reported to mediate Ca2+
oscillations and essential for osteoclast precursor differentiation
[25], thus intracellular ROS level is probably involved in the pro-
motion of TNF-a on calcium oscillation. Production of ROS associ-
ates to signals mediated by TNF-a [32,33]. It is not known whether
ROS contribute to TNF-a induced calcium oscillation, so we ﬁrstly
tested intracellular ROS level from 5 min to 48 h after stimulation
of RANKL with or without TNF-a. We observed that ROS level of
BMMs was up-regulated by RANKL at 24 h and 48 h. Our data is
consistent with the results reported by Kim et al. [25]. They found
that ROS production as well as calcium oscillaton in mouse BMMs
was elevated after the cells were stimulated for 24 h by RANKL.
However, addition of TNF-a in our work did not obviously increase
ROS level during the whole period of the culture. This result differs
from that of other studies which reported that TNF-a stimulate
ROS production [32,33]. The reason of such difference may due
to different cell types which have been studied. Another possibility
of the contradiction would be that RANKL activated NF-jB inhibits
ROS production induced by TNF-a. Hiroyasu Nakano et al. [34] re-
ported that TNF-a leaded to ROS accumulation in murine embry-
onic ﬁbroblasts (MEFs) which were deﬁcient in NF-jB p65
subunit, but not in wild-type MEFs. Another group demonstrated
that NF-jB antagonizes apoptosis induced by TNF-a through sup-
pressing the accumulation of ROS [35].
We further investigated another molecule involved in TNF-a
signaling. PC-PLC, associated with cell proliferation, apoptosis
and differentiation, is a molecule that produces DAG and phospho-
rylcholine from phosphatidylcholine (PC) hydrolysis. Many cyto-
kines such as TNF-a, LPS and IFN-c induce inﬂammatory
response and apoptosis through activating PC-PLC in different
types of cells [26–28]. It has been reported that TNF-a increases
the production of IP3R1 through PC-PLC activation in human neu-
ral cells and mesangial cells, leading to higher calcium-releasing
activity [24,29]. To examine the involvement of PC-PLC during
osteoclast differentiation induced by TNF-a, we used a speciﬁc
inhibitor of PC-PLC, D609. The toxicity of D609 was clariﬁed by
MTT assay. Cell viability was not affected by the chemical inhibitor
when cultured for 48 h. TRAP staining revealed that D609 moder-
ately increases the TRAP-positive MNCs number induced by RANKL
for 72 h, while remarkably decreased the number in the group of
RANKL combining TNF-a. These phenomena demonstrate that
PC-PLC may participate in the promotional effect of TNF-a on
osteoclastogenesis.
We next investigated how PC-PLC regulates NFATc1 autoampli-
ﬁcation and calcium associating molecules in this process. Our
results showed the amplitude of intracellular calcium oscillation
and NFATc1 expression in primary murine BMMs induced by
RANKL for 48 h were increased by addition of TNF-a. The IP3R1
mRNA expression was increased as well. However, the expression
of IP3R2 and IP3R3 mRNA were not changed, suggesting that IP3R1
may be probably involved in the upregulation of calcium oscilla-
tion and NFATc1 autoampliﬁcation. Increased expression of IP3R1
protein implicates more ligand-binding sites for IP3, thus recruited
more IP3 further leads to more sustainable calcium oscillation
resulting in the enhancement of autoampliﬁcation of NFATc1 andosteoclast formation. Adding D609 signiﬁcantly inhibited the regu-
lation of IP3R1 expression caused by adding TNF-a, the inhibition
conversely implicates a positive role of PC-PLC in signaling stimu-
lated by TNF-a during RANKL-induced osteoclastogenesis.
In conclusion, we found that D609 removed the promotional
effect of TNF-a on IP3R1 expression during osteoclast formation
induced by RANKL. The reducing effect of D609 on IP3R1 expres-
sion correlated to the downregulation of NFATc1 expression.
Exposing BMMs to D609 before the cells were conducted to differ-
entiation decreased TRAP-positive MNC number in the culture of
RANKL with TNF-a, while moderately increased the number in
RANKL without TNF-a. Our data indicate that PC-PLC is involved
in osteoclatogenesis induced by TNF-a probably through upregu-
lating IP3R1 expression. The precise mechanism by which TNF-a
stimulates osteoclastogenesis needs further discussion.
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